Abiopharma

🔍 MACFARLANE VICTOR B (Executive)

Company: Veris Residential, Inc. (VRE)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 110 shares of Phantom Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 26,034.14 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: The phantom stock units convert to common stock on a one-for-one basis.
• F2: The number of phantom stock units awarded is comprised of a quarterly dividend credited on cumulative phantom stock units under the Veris Residential, Inc. Deferred Compensation Plan for Directors.
• F3: The phantom stock units were accrued under the Veris Residential, Inc. Deferred Compensation Plan for Directors and are to be settled 100% in Veris Residential, Inc. common stock upon the termination of the reporting person's service on the Board of Directors of Veris Residential, Inc. or upon a change in control of Veris Residential, Inc.